FendX Completes Successful Pilot Scale-Up Run of REPELWRAP(TM) Film with Dunmore
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) has successfully completed a pilot scale-up run of its REPELWRAP™ film with Dunmore International Corp. The company reports that the produced film met performance expectations using a streamlined manufacturing process. Dr. Carolyn Myers, CEO of FendX, expressed satisfaction with the progress and stated that this advancement brings them closer to real-world testing with various industry partners in long-term care, fitness, and entertainment sectors.
FendX plans to conduct another pilot manufacturing run with Dunmore in the coming weeks, which they believe will be the final run before advancing to real-world testing. The company acknowledges the valuable collaboration with Dunmore and McMaster University in reaching this stage. Additionally, FendX granted 55,000 restricted share units (RSUs) to a consultant, vesting in three equal installments over the next three months.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) ha completato con successo una fase di collaudo su scala pilota del suo film REPELWRAP™ in collaborazione con Dunmore International Corp. L’azienda riferisce che il film prodotto ha soddisfatto le aspettative di prestazione utilizzando un processo produttivo semplificato. La Dott.ssa Carolyn Myers, CEO di FendX, ha espresso soddisfazione per i progressi ottenuti e ha dichiarato che questo sviluppo li avvicina ai test nel mondo reale con vari partner industriali nei settori della cura a lungo termine, del fitness e dell'intrattenimento.
FendX prevede di effettuare un'altra fase di produzione pilota con Dunmore nelle prossime settimane, che credono sarà l'ultima fase prima di passare ai test nel mondo reale. L'azienda riconosce la preziosa collaborazione con Dunmore e l'Università di McMaster per aver raggiunto questo stadio. Inoltre, FendX ha concesso 55.000 unità di azioni riservate (RSUs) a un consulente, con un'assegnazione in tre rate uguali nei prossimi tre mesi.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) ha completado con éxito una prueba de escala piloto de su película REPELWRAP™ con Dunmore International Corp. La empresa informa que la película producida cumplió con las expectativas de rendimiento utilizando un proceso de fabricación optimizado. La Dra. Carolyn Myers, CEO de FendX, expresó su satisfacción por los avances y declaró que este desarrollo los acerca a pruebas en el mundo real con varios socios de la industria en los sectores de atención a largo plazo, fitness y entretenimiento.
FendX planea realizar otra prueba de fabricación piloto con Dunmore en las próximas semanas, que creen será la última antes de avanzar hacia las pruebas en el mundo real. La empresa reconoce la valiosa colaboración con Dunmore y la Universidad de McMaster para haber alcanzado esta etapa. Además, FendX otorgó 55,000 unidades de acciones restringidas (RSUs) a un consultor, que se otorgarán en tres cuotas iguales durante los próximos tres meses.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)는 Dunmore International Corp.와 함께 REPELWRAP™ 필름의 파일럿 스케일업 시연에 성공적으로 완료하였습니다. 회사는 생산된 필름이 간소화된 제조 프로세스를 사용하여 성능 기대를 충족했다고 보고했습니다. FendX의 CEO인 Carolyn Myers 박사는 진행 상황에 대한 만족감을 표현하며, 이번 발전이 장기 요양, 피트니스 및 엔터테인먼트 분야의 다양한 산업 파트너들과의 실제 테스트에 더욱 가까워졌다고 밝혔습니다.
FendX는 향후 몇 주 내에 Dunmore와 함께 또 다른 파일럿 제조 시연을 진행할 계획이며, 이는 실제 테스트로 나아가기 전에 마지막 시연이 될 것으로 믿고 있습니다. 회사는 이 단계에 도달하기 위해 Dunmore 및 McMaster University와의 귀중한 협력 관계를 인정하였습니다. 또한, FendX는 55,000개의 제한 주식 단위(RSUs)를 교수에게 부여하였으며, 이는 향후 3개월 동안 세 번에 걸쳐 똑같이 배분됩니다.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) a réussi à compléter une démonstration à échelle pilote de son film REPELWRAP™ avec Dunmore International Corp. L'entreprise rapporte que le film produit a répondu aux attentes de performance grâce à un processus de fabrication simplifié. Dr. Carolyn Myers, PDG de FendX, a exprimé sa satisfaction concernant les progrès réalisés, déclarant que cette avancée les rapproche des tests en conditions réelles avec divers partenaires de l'industrie dans les secteurs des soins de longue durée, du fitness et du divertissement.
FendX prévoit de réaliser une autre production pilote avec Dunmore dans les prochaines semaines, qu'ils estiment être la dernière avant de passer aux tests en conditions réelles. L'entreprise reconnaît la précieuse collaboration avec Dunmore et l'Université de McMaster pour avoir atteint cette étape. De plus, FendX a attribué 55 000 unités d'actions restrictives (RSUs) à un consultant, qui seront acquises en trois versements égaux au cours des trois prochains mois.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) hat erfolgreich einen Pilotversuch zur Skalierung seiner REPELWRAP™-Folien in Zusammenarbeit mit Dunmore International Corp. abgeschlossen. Das Unternehmen berichtet, dass der produzierte Film die Leistungserwartungen unter Verwendung eines optimierten Herstellungsprozesses erfüllt hat. Dr. Carolyn Myers, CEO von FendX, zeigte sich über die Fortschritte erfreut und erklärte, dass dieser Fortschritt sie näher an reale Tests mit verschiedenen Industriepartnern im Bereich der Langzeitpflege, Fitness und Unterhaltung bringt.
FendX plant in den kommenden Wochen eine weitere Pilotproduktionsreihe mit Dunmore, von der sie glauben, dass es der letzte Schritt vor den realen Tests sein wird. Das Unternehmen erkennt die wertvolle Zusammenarbeit mit Dunmore und der McMaster University an, die sie an diesen Punkt gebracht hat. Darüber hinaus hat FendX einem Berater 55.000 Restricted Share Units (RSUs) gewährt, die in drei gleichen Teilbeträgen über die nächsten drei Monate gewährt werden.
- Successful completion of pilot scale-up run for REPELWRAP™ film
- Film met performance expectations with streamlined manufacturing process
- Progress towards real-world testing with industry partners in diverse sectors
- Planned final pilot manufacturing run in the coming weeks
- None.
Oakville, Ontario--(Newsfile Corp. - July 24, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX") a nanotechnology company developing surface protection coatings, is pleased to announce that it continues to progress towards finalizing the film manufacturing process with Dunmore International Corp. ("Dunmore").
This last pilot manufacturing run confirmed the film that was produced met performance expectations using a streamlined manufacturing process. The Company believes the insights gained from this pilot run advance the Company's progress toward finalizing the manufacturing process.
Dr. Carolyn Myers, CEO of FendX states: "We are pleased with the progress we are making to advance the manufacturing process, bringing us closer to preparing for real-world testing with the various industry partners we have announced over the past couple of months. These testing partnerships span a diverse range of venues including long-term care, fitness and entertainment." Dr. Myers continues, "We plan to conduct another pilot manufacturing run with Dunmore in the coming weeks and believes this will be the final run before advancing to real-world testing. We thank Dunmore and McMaster University for their expertise and commitment to assist with getting us to this point. This collaboration has been invaluable."
The Company also announces it granted 55,000 restricted share units ("RSUs") to a consultant. The RSUs vest as to 1/3 of the grant on each of August 19, 2024, September 19, 2024 and October 18, 2024. The RSUs were granted in accordance with the Company's equity incentive plan dated October 19, 2021. All of the stock options and RSUs are subject to a hold period of four months and one day from the date of grant.
About Dunmore International Corp.
Dunmore International Corp., a Steel Partners Holdings L.P. (NYSE: SPLP) operating company, is a global manufacturer of engineered coated and laminated films and foils with manufacturing facilities in the U.S. and Germany. Dunmore offers film conversion services such as coating, metallizing, and laminating along with contract film manufacturing and custom film product development. Dunmore services a diverse group of industries including aircraft, spacecraft, photovoltaic, graphic arts & labels, packaging, and insulation. Dunmore is a subsidiary of Steel Partners and is ISO 9001:2015 and OSHA VPP Star certified.
About FendX Technologies Inc.
FendX is a Canada-based nanotechnology company focused on developing products to make people's lives safer by reducing the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP™ film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners, including McMaster University. The Company has exclusive worldwide licenses to its technology and IP portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.
ON BEHALF OF FENDX TECHNOLOGIES INC.
"Carolyn Myers"
Carolyn Myers
Chief Executive Officer and Director
Contacts:
Dr. Carolyn Myers, CEO and Director
1-800-344-9868
investor@fendxtech.com
For more information, please visit https://fendxtech.com and the Company's profile on SEDAR+ at www.sedarplus.ca.
Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; statements regarding continuing to progress towards finalizing the film manufacturing process with Dunmore; statements regarding refining and finalizing the film manufacturing process and advancing towards real-world testing of REPELWRAP™ film; statements regarding the anticipated successful completion of scale-up work with Dunmore; statements regarding conducting an additional pilot manufacturing run and believing this will be the final run before advancing to real-world testing; statements regarding the intention to conduct real-world testing with announced test sites and any timing related thereto; and products under development and any pathogen reduction benefits related thereto. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "aims," "potential," "goal," "objective," "prospective," and similar expressions, or that events or conditions "will," "would," "may," "can," "could" or "should" occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made and involve several risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and that actual results and future events could differ materially from those anticipated in such statements.
Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include: product candidates only being in formulation/reformulation stages; limited operating history; research and development activities; dependence on collaborative partners, licensors and others; effect of general economic and political conditions; and other risk factors set forth in the Company's public filings which are available on SEDAR+ at www.sedarplus.ca. Accordingly, the reader is urged to refer to the Company's such filings for a more complete discussion of such risk factors and their potential effects. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors should change.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/217486
FAQ
What was the outcome of FendX Technologies' (FDXTF) recent pilot scale-up run with Dunmore?
When does FendX Technologies (FDXTF) plan to conduct its next pilot manufacturing run?
In which sectors does FendX Technologies (FDXTF) plan to conduct real-world testing of its REPELWRAP™ film?
How many restricted share units (RSUs) did FendX Technologies (FDXTF) grant in July 2024?
